Genetic News and Research

RSS

Osiris Therapeutics net income increases to $4.0 million for first quarter 2011

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, cardiovascular, wound care and orthopedic areas, announced today its results for the first quarter ended March 31, 2011.

10 May 2011

Nexvax2- coeliac disease vaccine shows promising results in Phase I clinical trial

The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.

10 May 2011

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.

10 May 2011

Genetic mutation linked to Kufs disease

According to a new study, a genetic mutation thought to be responsible for the rare hereditary brain disorder Kufs disease is finally identified. The research was carried out by Dr Melanie Bahlo and her team at the Walter and Eliza Hall Institute's bioinformatics department in Parkville, Australia, in partnership with neurologist and epilepsy specialists Professor Sam Berkovic and Dr Todor Arsov from the University of Melbourne, Australia.

10 May 2011

Dravet Syndrome Foundation awards OPKO Health grant to develop potential therapeutic agents

OPKO Health, Inc. announced today that it has been awarded a grant from the Dravet Syndrome Foundation to support the Company's efforts to develop potential therapeutic agents to treat a rare genetic disorder, Dravet Syndrome, also called severe myoclonic epilepsy of infancy, a severe form of epilepsy that usually appears during the first year of life.

9 May 2011

Viewpoints: Dems' Medicare strategy; Health disparities; Chicago hospital dispute

Democrats may be feeling smug about their campaign against the House Republican budget plan, and as a matter of politics, they're no doubt right. If the goal is to deal with the long-term fiscal challenge, though, the Democrats' political success is apt only to prolong the gridlock and make the eventual solution that much more painful. ...

9 May 2011

Three Ontario projects set to further knowledge and discovery in biomonitoring, drug development

As part of the Genome Canada Large-Scale Applied Research Project Competition, which as a whole awarded over $58 million to 16 projects across the country, the researchers in Ontario will be focusing on biomonitoring, understanding gene function with the aim of identifying genes or proteins for drug targets, and the creation of synthetic antibodies to target cancers and other diseases.

9 May 2011

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR® technology for high-resolution genetic reassortment ("gene shuffling").

9 May 2011

Psychotherapeutic treatment can cure cyclothymic disorder

In the current issue of Psychotherapy and Psychosomatics a group of Italian investigators headed by Giovanni Fava published a randomized controlled trial on psychotherapeutic treatment of cyclothymic disorder, a disturbance that is characterized by rapid alternation of mood swings.

9 May 2011

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Cardiologists from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research at The Heart Rhythm Society's 32nd Annual Scientific Sessions, May 4 -7 in San Francisco, California.

9 May 2011

Breast cancer linked to lifestyle & three new genes

According to the latest research as many as 20,000 British women could avoid developing breast cancer if they took more exercise, drank less and ate better. The World Cancer Research Fund recommends taking half an hour of physical exercise a day, limiting alcohol consumption to just one drink daily and losing weight.

8 May 2011

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."

7 May 2011

Breast cancer cells utilize tissue stem cell EMT for tumor metastasis

Researchers at the University of North Carolina at Chapel Hill School of Medicine, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer.

7 May 2011

Filipino children with KD at greater risk for inflammation of heart blood vessels

While children of all ethnicities can contract Kawasaki disease (KD), a study led by researchers at the Kawasaki Disease Research Center at the University of California, San Diego and Rady Children's Hospital-San Diego finds that Filipino children with KD are at a higher risk for inflammation of the blood vessels of the heart than those of other Asian and non-Asian backgrounds.

7 May 2011

New cardiac genetic testing guidelines for health care professionals

An international panel of experts from The Heart Rhythm Society and the European Heart Rhythm Association issued new guideline recommendations for all health care professionals about cardiovascular genetic testing at the Heart Rhythm Society's 32nd Annual Scientific Sessions.

7 May 2011

NYU, LaSalle University develop new effective asthma-related anxiety tool

When children or adolescents with asthma and their parents become overly anxious about the disorder, it may impair their ability to manage the asthma effectively. A new, effective tool to assess asthma-related anxiety is described in an article in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

6 May 2011

CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society meeting

Cambridge Heart, Inc. a developer of non-invasive diagnostic tests for cardiac disease, today announced that new data presented at the Heart Rhythm Society's 32nd Annual Scientific Sessions in San Francisco confirm the diagnostic value of Microvolt T-wave Alternans testing in identifying patients at risk of sudden cardiac arrest.

6 May 2011

Scientists use new technologies to identify genetic cause of Kufs disease

Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy.

6 May 2011

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Using a monkey model of AIDS, scientists have identified a vaccine-generated immune-system response that correlates with protection against infection by the monkey version of HIV, called simian immunodeficiency virus (SIV). The researchers found that neutralizing antibodies generated by immunization were associated with protection against SIV infection.

6 May 2011

Scripps Research receives CIRM grant for new research in stem cell biology and disease origins

Stem cells have huge potential in medicine because they have the ability to change or differentiate into many different cell types potentially providing a source of cells to replace those that have been permanently lost by a patient.

6 May 2011

Genetic News and Research

Osiris Therapeutics net income increases to $4.0 million for first quarter 2011

Nexvax2- coeliac disease vaccine shows promising results in Phase I clinical trial

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Genetic mutation linked to Kufs disease

Dravet Syndrome Foundation awards OPKO Health grant to develop potential therapeutic agents

Viewpoints: Dems' Medicare strategy; Health disparities; Chicago hospital dispute

Three Ontario projects set to further knowledge and discovery in biomonitoring, drug development

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Psychotherapeutic treatment can cure cyclothymic disorder

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Breast cancer linked to lifestyle & three new genes

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Breast cancer cells utilize tissue stem cell EMT for tumor metastasis

Filipino children with KD at greater risk for inflammation of heart blood vessels

New cardiac genetic testing guidelines for health care professionals

NYU, LaSalle University develop new effective asthma-related anxiety tool

CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society meeting

Scientists use new technologies to identify genetic cause of Kufs disease

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Scripps Research receives CIRM grant for new research in stem cell biology and disease origins

Sequencing & Genomics: Elevating Science and Healthcare eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News